These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria. Haque A; Best SE; Unosson K; Amante FH; de Labastida F; Anstey NM; Karupiah G; Smyth MJ; Heath WR; Engwerda CR J Immunol; 2011 Jun; 186(11):6148-56. PubMed ID: 21525386 [TBL] [Abstract][Full Text] [Related]
4. Malaria-specific and nonspecific activation of CD8+ T cells during blood stage of Plasmodium berghei infection. Miyakoda M; Kimura D; Yuda M; Chinzei Y; Shibata Y; Honma K; Yui K J Immunol; 2008 Jul; 181(2):1420-8. PubMed ID: 18606696 [TBL] [Abstract][Full Text] [Related]
5. Pathogenic T cells in cerebral malaria. Rénia L; Potter SM; Mauduit M; Rosa DS; Kayibanda M; Deschemin JC; Snounou G; Grüner AC Int J Parasitol; 2006 May; 36(5):547-54. PubMed ID: 16600241 [TBL] [Abstract][Full Text] [Related]
6. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA. Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878 [TBL] [Abstract][Full Text] [Related]
10. Perivascular Arrest of CD8+ T Cells Is a Signature of Experimental Cerebral Malaria. Shaw TN; Stewart-Hutchinson PJ; Strangward P; Dandamudi DB; Coles JA; Villegas-Mendez A; Gallego-Delgado J; van Rooijen N; Zindy E; Rodriguez A; Brewer JM; Couper KN; Dustin ML PLoS Pathog; 2015; 11(11):e1005210. PubMed ID: 26562533 [TBL] [Abstract][Full Text] [Related]
11. Infection-Induced Resistance to Experimental Cerebral Malaria Is Dependent Upon Secreted Antibody-Mediated Inhibition of Pathogenic CD8 Shaw TN; Inkson CA; Villegas-Mendez A; Pattinson DJ; Strangward P; Else KJ; Draper SJ; Zeef LAH; Couper KN Front Immunol; 2019; 10():248. PubMed ID: 30846985 [TBL] [Abstract][Full Text] [Related]
12. PDL1 Fusion Protein Protects Against Experimental Cerebral Malaria via Repressing Over-Reactive CD8 Wang J; Li Y; Shen Y; Liang J; Li Y; Huang Y; Liu X; Jiang D; Yang S; Zhao Y; Yang K Front Immunol; 2018; 9():3157. PubMed ID: 30693001 [TBL] [Abstract][Full Text] [Related]
19. On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. Belnoue E; Kayibanda M; Vigario AM; Deschemin JC; van Rooijen N; Viguier M; Snounou G; Rénia L J Immunol; 2002 Dec; 169(11):6369-75. PubMed ID: 12444144 [TBL] [Abstract][Full Text] [Related]
20. The Liver-Stage Sato Y; Ries S; Stenzel W; Fillatreau S; Matuschewski K Front Immunol; 2019; 10():2554. PubMed ID: 31736970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]